Primary Research Development from 2010 to 2024

PHP Stock   94.15  0.85  0.89%   
Primary Health's Research Development is decreasing over the years with slightly volatile fluctuation. Research Development is expected to dwindle to 0.14. During the period from 2010 to 2024 Primary Health Research Development annual values regression line had geometric mean of  0.56 and mean square error of  0.08. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
0.15
Current Value
0.14
Quarterly Volatility
0.29090172
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Primary Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Primary Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 945 K, Interest Expense of 49.8 M or Total Revenue of 178.3 M, as well as many indicators such as . Primary financial statements analysis is a perfect complement when working with Primary Health Valuation or Volatility modules.
  
This module can also supplement various Primary Health Technical models . Check out the analysis of Primary Health Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Primary Stock

Primary Health financial ratios help investors to determine whether Primary Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Primary with respect to the benefits of owning Primary Health security.